Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.
Sentonix is a pharmaceutical company that offers immuno-therapy service for cancer treatment.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Volta Labs develops scalable automation for genetic engineering.
Haystack Oncology enables precision oncology to optimize treatment strategies.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.
Bridging the gap between patients and researchers
Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Catalio Capital Management has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Health Care, Biotechnology, Medical, Life Science, Health Diagnostics. The firm invests across 27 different industry categories.
Among tracked funding rounds, Parabilis Medicines received $305.0M in a Series F round. Catalio Capital Management's total known invested capital is $7.8B.
Catalio Capital Management's average investment size is $75.2M across its portfolio of 137 companies.
Recent Catalio Capital Management portfolio additions include PrognomiQ, Sherlock Biosciences, Sentonix, Thrive Earlier Detection, Volta Labs. These companies were founded in 2020 or later.